Odyssey Health, Inc. (ODYY) stock
ODYYOTCSurgical & Medical Instruments & ApparatusFiscal year ends July 31
$0.01−0.00 (-16.25%)
Close on Oct 19, 2026Market cap $746.34KP/E –Yield –
Odyssey Health operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Odyssey Health's operating income for the twelve months ending Jul 31, 2026 was -$912.99K. For fiscal 2026 it was -$912.99K. The highest annual figure on record is -$73.57K in fiscal 2016.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jul 31, 2026 | -$912.99K | – |
| FY2025 | Jul 31, 2025 | -$1.02M | – |
| FY2024 | Jul 31, 2024 | -$2.14M | – |
| FY2023 | Jul 31, 2023 | -$5.31M | – |
| FY2022 | Jul 31, 2022 | -$8.11M | – |
| FY2021 | Jul 31, 2021 | -$15.86M | – |
| FY2020 | Jul 31, 2020 | -$3.85M | – |
| FY2019 | Jul 31, 2019 | -$23.58M | – |
| FY2018 | Jul 31, 2018 | -$420.44K | – |
| FY2017 | Jul 31, 2017 | -$167.58K | – |
| FY2016 | Jul 31, 2016 | -$73.57K | – |
| FY2015 | Jul 31, 2015 | -$155.90K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jul 31, 2026 | -$130.31K | – |
| Q3 FY2026CQ1 2026 | Apr 30, 2026 | -$297.55K | – |
| Q2 FY2026CQ4 2025 | Jan 31, 2026 | -$181.94K | – |
| Q1 FY2026CQ3 2025 | Oct 31, 2025 | -$303.19K | – |
| Q4 FY2025CQ2 2025 | Jul 31, 2025 | -$155.68K | -165.6% |
| Q3 FY2025CQ1 2025 | Apr 30, 2025 | -$129.06K | – |
| Q2 FY2025CQ4 2024 | Jan 31, 2025 | -$156.59K | – |
| Q1 FY2025CQ3 2024 | Oct 31, 2024 | -$579.43K | – |
| Q4 FY2024CQ2 2024 | Jul 31, 2024 | $237.43K | – |
| Q3 FY2024CQ1 2024 | Apr 30, 2024 | -$372.37K | – |
| Q2 FY2024CQ4 2023 | Jan 31, 2024 | -$1.16M | – |
| Q1 FY2024CQ3 2023 | Oct 31, 2023 | -$347.24K | – |
| Q4 FY2023CQ2 2023 | Jul 31, 2023 | -$655.11K | – |
| Q3 FY2023CQ1 2023 | Apr 30, 2023 | -$1.09M | – |
| Q2 FY2023CQ4 2022 | Jan 31, 2023 | -$1.49M | – |
| Q1 FY2023CQ3 2022 | Oct 31, 2022 | -$2.08M | – |
| Q4 FY2022CQ2 2022 | Jul 31, 2022 | -$1.83M | – |
| Q3 FY2022CQ1 2022 | Apr 30, 2022 | -$2.87M | – |
| Q2 FY2022CQ4 2021 | Jan 31, 2022 | -$1.98M | – |
| Q1 FY2022CQ3 2021 | Oct 31, 2021 | -$1.43M | – |
| Q4 FY2021CQ2 2021 | Jul 31, 2021 | -$2.61M | – |
| Q3 FY2021CQ1 2021 | Apr 30, 2021 | -$12.09M | – |
| Q2 FY2021CQ4 2020 | Jan 31, 2021 | -$633.79K | – |
| Q1 FY2021CQ3 2020 | Oct 31, 2020 | -$525.27K | – |
| Q4 FY2020CQ2 2020 | Jul 31, 2020 | -$1.16M | – |
| Q3 FY2020CQ1 2020 | Apr 30, 2020 | -$867.67K | – |
| Q2 FY2020CQ4 2019 | Jan 31, 2020 | -$499.75K | – |
| Q1 FY2020CQ3 2019 | Oct 31, 2019 | -$1.32M | – |
| Q4 FY2019CQ2 2019 | Jul 31, 2019 | -$23.39M | – |
| Q3 FY2019CQ1 2019 | Apr 30, 2019 | -$45.19K | – |
| Q2 FY2019CQ4 2018 | Jan 31, 2019 | -$89.76K | – |
| Q1 FY2019CQ3 2018 | Oct 31, 2018 | -$52.40K | – |
| Q4 FY2018CQ2 2018 | Jul 31, 2018 | -$81.79K | – |
| Q3 FY2018CQ1 2018 | Apr 30, 2018 | -$57.40K | – |
| Q2 FY2018CQ4 2017 | Jan 31, 2018 | -$231.76K | – |
| Q1 FY2018CQ3 2017 | Oct 31, 2017 | -$49.50K | – |
| Q4 FY2017CQ2 2017 | Jul 31, 2017 | -$53.24K | – |
| Q3 FY2017CQ1 2017 | Apr 30, 2017 | -$72.40K | – |
| Q2 FY2017CQ4 2016 | Jan 31, 2017 | -$26.03K | – |
| Q1 FY2017CQ3 2016 | Oct 31, 2016 | -$15.91K | – |
See a number that looks wrong?